Cti Biopharma reported $62.34M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Applied Genetic Technologies AGTC:US $ 21.71M 2M
Baxter International BAX:US $ 3441M 97M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Cti Biopharma CTIC:US $ 62.34M 46.55M
Cytori Therapeutics CYTX:US $ 9.49M 1.13M
Eli Lilly And LLY:US $ 13682M 1411.2M
Geron GERN:US $ 38.47M 1.46M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Northwest Biotherapeutics NWBO:US 312.32M 48.39M
Novartis NVS:US $ 29880M 247M
Novartis NOVN:VX SF 29880M 247M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Sunesis Pharmaceuticals SNSS:US $ 7.16M 0.21M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
YTE INCY:US $ 742.71M 82.39M